Inozyme Pharma, Inc. (INZY) Operating Lease, Liability USD 2021 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Inozyme Pharma, Inc. quarterly Operating Lease, Liability history and growth rate from 2021 to 2024.
  • Inozyme Pharma, Inc. Operating Lease, Liability for the quarter ending March 31, 2024 was $300 K, unchanged year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $300 K $0 0% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $700 K -$200 K -22.2% Dec 31, 2023 10-K 2024-03-12
Q3 2023 $700 K +$100 K +16.7% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $500 K $0 0% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $300 K +$100 K +50% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $900 K Dec 31, 2022 10-K 2024-03-12
Q3 2022 $600 K Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $500 K -$3.2 M -86.5% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $200 K -$3.7 M -94.9% Mar 31, 2022 10-Q 2022-05-10
Q2 2021 $3.7 M Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $3.9 M Mar 31, 2021 10-Q 2021-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.